help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 27, 2003, doi:10.1165/rcmb.2002-0197OC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0197OCv1
29/3/359    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kume, H.
Right arrow Articles by Kotlikoff, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kume, H.
Right arrow Articles by Kotlikoff, M. I.
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 359-366, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2002-0197OC

Involvement of Ca2+ Mobilization in Tachyphylaxis to ß-Adrenergic Receptors in Trachealis

Hiroaki Kume, Takayuki Ishikawa, Tetsuya Oguma, Satoru Ito, Kaoru Shimokata and Michael I. Kotlikoff

Division of Respiratory Medicine, Department of Medicine, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan; and Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York

Address correspondence to: Hiroaki Kume, M.D., Ph.D., Division of Respiratory Medicine, Department of Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466–8550, Japan. E-mail: hkume{at}med.nagoya-u.ac.jp


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We examined the mechanisms underlying tachyphylaxis to ß-adrenergic receptor agonists (ß-agonists) in tracheal smooth muscle. Simultaneous measurements of isometric tension and intracellular Ca2+ concentration ([Ca2+]i) using fura-2–loaded guinea pig tracheas showed that the inhibitory effects of isoproterenol (ISO) on tension and increases in [Ca2+]i induced by methacholine exhibited marked tachyphylaxis with repeated exposure to ISO at intervals of 15 min. Similarly, the activation of single Ca2+-activated K+ (KCa) channels in on-cell patches by 1 µM ISO was gradually attenuated after repeated extracellular application of ISO to single smooth cells of porcine tracheas. Desensitization of ß-adrenergic receptor/KCa channel stimulatory coupling and relaxation responses was prevented by separately antagonizing the voltage-dependent Ca2+ channel (VDCC) with verapamil, suggesting a surprising relationship between Ca2+ influx through VDCC and ß-adrenergic desensitization. Conversely, repeated exposure of 10 U/ml protein kinase A to inside-out patches did not result in desensitization of channel activation, and repeated exposure to 10 µM forskolin modestly augmented the inhibitory effects of forskolin on tension and [Ca2+]i by methacholine, indicating that the mechanism of desensitization is mediated by the ß-adrenergic receptor/G protein complex. These results indicate that an uncoupling of ß-adrenergic receptor from KCa channels augments Ca2+ mobilization through VDCC and stimulates tachyphylaxis.

Abbreviations: intracellular Ca2+ concentration, [Ca2+]i • dimethyl sulfoxide, DMSO • ethyleneglycol-bis-(ß-aminoethyl ether)-N,N',-tetraacetic acid, EGTA • isoproterenol, ISO • Ca2+-activated K+, KCa • open probability, nPo • voltage-dependent Ca2+ channel, VDCC


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Repeated or continuous exposure of smooth muscle tissue to ß-adrenergic receptor agonists (ß-agonists) results in a decline in agonist activity, referred to as tachyphylaxis or desensitization. In vitro, repeated exposure of guinea pig (1) and human (2) tracheal smooth muscle to ß-agonists results in the gradual attenuation of relaxation responses. Similarly, repeated inhalation of ß-agonists causes a reduction in bronchodilation by ß-agonists in anesthetized dogs in vivo (3), and clinical trials have demonstrated that regular administration of inhaled ß-agonists may cause not only a deterioration of asthma control and an exacerbation of airway hyperreactivity (4), but also may accelerate a decline in lung function in patients with asthma (5). Moreover, excessive inhalation of ß-agonists causes a decrease in the bronchodilator effects induced by ß-agonists, and in the protective effects of ß-agonists against bronchoconstriction induced by muscarinic agonists (6, 7). Desensitization to ß-adrenergic receptors may not only complicate asthma therapy, but may also play a role in the pathophysiology of bronchial asthma. Thus reduced responsiveness to ß-agonists is observed after continuous exposure to interleukin-1ß and tumor necrosis factor-{alpha}, proinflammatory cytokines involved in airway inflammation in the disease (8, 9) and continuous exposure to lysophosphatidylcholine, a lysophospholipid which is synthesized by phospholipase A2, causes desensitization of ß-adrenergic receptors in airway smooth muscle (10).

Relaxation of airway smooth muscle is particularly dependent on stimulatory coupling between ß-adrenergic receptors and large conductance Ca2+-activated K+ (KCa) channels (1113), as well as by other mechanisms (14). This stimulatory coupling is mediated by both cAMP-dependent (15, 16) and -independent (17) pathways. cAMP-independent pathways associated with the direct stimulation of KCa channels by the stimulatory GTP-binding (G) protein of adenylyl cyclase, GS, have recently been shown to be involved in ß-adrenergic actions (18). Here we examined the degree to which this stimulatory coupling is involved in the prominent tachyphylaxis observed in ß-adrenergic relaxation responses. Specifically, we sought to determine whether ß-adrenergic linkage to KCa channels and Ca2+ mobilization exhibited this phenomenon and whether adenylyl cyclase activity is involved in the tachyphylaxis to ß-agonists. Our findings indicate that ß-adrenergic stimulatory coupling to KCa channels displays marked tachyphylaxis and that the desensitization of this coupling likely underlies the progressive loss of functional muscle relaxation.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Tissue Preparation and Tension Records
Methods were essentially similar to those described previously (19). Male guinea pigs (350–450 g) were killed and tracheas excised from the animal. The tracheal ring was opened by cutting longitudinally through the cartilaginous region, and the epithelium was dissected away. Muscle strips containing one cartilaginous ring were removed and placed vertically in a 1-ml organ bath to measure tension isometrically, and perfused with solution at a constant flow rate 2.0 ml/min throughout the experiments. The normal bath solution had the following composition (mM): 137 NaCl, 5.9 KHCO3, 2.4 CaCl2,1.2 MgCl2, and 11.8 glucose, bubbled with a gas mixture of 99% O2–1% CO2. For the Ca2+-free solution, 2.4 mM CaCl2 was replaced with 2.2 mM NaCl and 0.2 mM ethyleneglycol-bis- (ß-aminoethyl ether)-N,N',-tetraacetic acid (EGTA). Indomethacin (2 µM) was perfused throughout the experiments to abolish resting tone and passive tension was adjusted to 0.5 g after equilibrating the preparation in the normal bath solution for 60 min. One micromolar methacholine (MCh) was applied to the strips for 10 min at intervals of 20 min until the control response to 1 µM MCh was established, then the experiments were started. One micromolar MCh was repeatedly applied in the presence of 0.3 µM isoproterenol (ISO) at an interval of 30 min. ISO was applied 3 min before MCh. The relaxation observed following exposure to Ca2+-free solution, applied at the end of each experiment, was defined as complete relaxation (0% contraction). All experiments were performed at 37°C.

Measurement of Fura-2 Fluorescence
Guinea pig tracheal muscle strips were treated with 10 µM acetoxymethyl ester of fura-2 (fura-2/AM) for 4 h at room temperature (22–24°C). The noncytotoxic detergent, pluronic F-127 (0.01% wt/vol), was added to increase the solubility of fura-2/AM. After loading, tissues were placed horizontally in a chamber and perfused with normal bath solution for 50 min at 37°C to wash out the extracellular fura-2/AM before the measurements were made. Isometric tension and fura-2 fluorescence of muscle strips were measured simultaneously (20), using a displacement transducer and a spectrofluorometer (CAF-110; Japan Spectroscopic, Tokyo, Japan). The mucosal side of the muscle strips was exposed to excitation light, and fluorescent light emitted from the strip was collected into a photomultiplier through a 500-nm high pass filter. The intensity of fluorescence at 340 nm (F340) and at 380 nm (F380) excitation were measured after background subtraction. Results are not reported as intracellular Ca2+ concentration ([Ca2+]i) values, as the dissociation constant of fura-2 for Ca2+ in smooth muscle cytoplasm may be different from that obtained in vitro. Rather, the ratio of F340 to F380 (F340/F380) was used as a relative indicator of [Ca2+]i. To assess the contamination of Ca2+-independent fluorescence mediated by intermediate metabolites of fura-2/AM, photobleached fura-2 and changes in the cell geometry, we checked that Ca2+-dependent changes in F340 and F380 were symmetrical. The level of muscle tension and the F340/F380 in the resting state were defined as 0% and the peak tension and F340/F380 observed following exposure to 1 µM MCh were defined as 100%.

Single-Channel Records
Due to difficulties in dispersing physiologically responsive tracheal smooth muscle cells from the guinea pigs, we used porcine tracheal myocytes, which have similar pharmacologic characteristics, for single-channel studies. Porcine tracheal myocytes were enzymaticaly dissociated from porcine trachea according to previous methods (21). The solution for cell dispersion contained colagenase (300 U/ml, type D; Boehringer Mannheim Biochemicals, Mannheim, Germany), elastase (8 U/ml; Worthington Biochemical Co., Lakewood, NJ), soybean tripsin inhibitor 1 mg/ml, and EGTA 1.8 mM. After gentle agitation for 30 min in the enzyme solution, single smooth muscle cells were obtained. Single-channel currents were recorded using standard patch clamp technique. Currents records were filtered at 200 Hz or 1 kHz, and digitized at 1 or 5 kHz, respectively. Channel open-state probability is described as nPo, because the total number of channels in any given patches (n) was not determined, similar to previous reports. Values of nPo were determined using half-crossing analysis. The internal solution (cytosolic patch surface) was (in mM): 126 KCl, 5 NaCl, 1 MgCl2, 2.5 EGTA, and 10 HEPES adjusted to 7.2 with KOH; CaCl2 was added to adjust free Ca2+ to 0.1 µM. The external solution (extracellular patch surface) was (in mM): 125 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, and 10 HEPES adjusted to 7.4 with NaOH. Single-channel records were performed at room temperature (22–24°C).

cAMP Measurement
Measurement of concentration of intracellular cAMP was performed as previously described (22, 23). Trachealis muscle strips were dissected from tracheae of guinea pigs as described above and the epithelium denuded by gentle rubbing. Muscle strips (~ 2 x 2 x 10 mm) were cut by dissecting parallel to the longitudinal axis of the muscle and equilibrated in normal bath solution at 37° for 60 min, and then the experiments started. Two micromolars indomethacin was perfused throughout the experiments. At the end of each experiment, the strips were rapidly removed, blotted, and frozen in liquid nitrogen. Frozen strips were homogenized in cold 6% trichloroacetic acid at 2–8°C and the homogenate centrifuged at 2,000 x g for 15 min at 4°C. Precipitated protein was separated and used for the measurement of protein content (24). The supernatant was washed 4x with 5 vols of water-saturated diethyl ether, and the aqueous extract remaining was lyophilized for assay for cAMP content. The concentrations of cAMP were estimated, using a commercially available enzyme-immunoassay kit (RPN 225; Amersham Life Sciences, Buckinghamshire, UK) without acetylation. cAMP content was expressed as picomoles of cAMP per milligram of protein.

Materials
MCh, ISO, forskolin, verapamil, soybean tripsin inhibitor, the catalytic subunit of PKA, EGTA, HEPES, and indomethacin were obtained from Sigma Chemical Co. (St. Louis, MO). IbTX was obtained from Osaka Peptide Corporation (Osaka, Japan) and fura-2/AM from Dojin Laboratories (Kumamoto, Japan). Fura-2/AM was dissolved in dimethyl sulfoxide (DMSO), and the final DMSO concentration was less than 0.5%. Neither drug affected the fura-2 fluorescence at the concentration used.

Analysis of Results
All data are expressed as mean ± S.D. The responses to an agent under each condition are described as a percentage of the control response. Values of concentration of relaxant agents that produce 50% inhibition (EC50) of contraction induced by 1 µM MCh were determined using linear regression analysis applied to the linear portion of each concentration-response curve. Parameters were compared using the unpaired Student's t test, and P values of < 0.05 were considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Desensitization of ß-Adrenergic Relaxation
The trachealis strips were repeatedly contracted (every 30 min) with 1 µM MCh after pretreatment with 0.3 µM ISO (3 min before contraction). As shown in Figure 1A (upper trace), this protocol resulted in a gradual attenuation of relaxant effects from almost complete inhibition of contraction to only slight inhibition of control contractions. The values of percent contraction at the first and ninth application were 1.2 ± 0.6 and 72.9 ± 6.4% (n = 12), respectively (P < 0.01, Figure 1B). The desensitization of ß-adrenergic relaxation was markedly dependent on voltage-dependent calcium influx, as the same protocol in the presence of 3 µM verapamil prevented the loss of ISO efficacy (Figure 1A, middle trace). The value of percent contraction for MCh with ISO at the ninth application were decreased to 14.2 ± 5.6% (n = 12, P < 0.001, Figure 1B). Similar effects were observed with equimolar nifedipine. Conversely, the KCa channel inhibitor IbTX (30 nM) reduced the inhibitory effects of ISO and resulted in a rapid loss of relaxation efficacy after repeated exposure (Figure 1A, lower trace). The values of percent contraction for MCh with ISO at the first application were 31.4 ± 4.9%, and those values were increased to 100% at the sixth application (n = 12, Figure 1B). In control experiments repeated application of 1 µM MCh did not result in a significant attenuation of contractile responses. The values of percent contraction for MCh at the tenth applications of this agent was 96.8 ± 2.9% (n = 4, data not shown).




View larger version (35K):
[in this window]
[in a new window]
 
Figure 1. Subsequent relaxation by a ß-agonist after repeated exposure to an agent. (A) A continuous typical record of the inhibitory effects of 0.3 µM ISO on 1 µM MCh-induced contraction after repeated exposure to these agents (upper trace). Typical continuous records of the inhibitory effects of ISO on MCh after repeated exposure to these agents in the presence of 3 µM verapamil (middle trace) and 30 nM IbTX throughout the experiments (lower trace). (B) Relationship between percent contraction for MCh with ISO inhibition and the number of applications of these agents. Open circles, control; closed circles, in the presence of verapamil; open squares, in the presence of IbTX.

 
Stimulation of Adenylyl Cyclase and Desensitization
We next examined the desensitization of direct adenylyl cyclase stimulation. Using 1 µM forskolin in place of ISO in protocols identical to those shown in Figure 1, the inhibitory effects of forskolin were not attenuated over time (Figure 2A, upper trace), as was observed with ISO. The values of percent contraction for MCh with forskolin at the first and ninth application were 66.9 ± 9.9 and 73.5 ± 6.6% (n = 12), respectively (not significant; Figure 2B). The same result was observed when the concentration of forskolin was increased 10-fold (10 µM) to achieve almost total inhibition of contraction; rather than demonstrating tachyphylaxis, the inhibitory effects of 10 µM forskolin on 1 µM MCh were gradually augmented after repeated exposure (Figure 2A, lower trace). The values of percent contraction with MCh with forskolin at the first and ninth application were 8.0 ± 3.9 and 1.3 ± 0.6% (n = 12), respectively (P < 0.01, Figure 2B). However, in the presence of 30 nM IbTX, the inhibitory effects of 10 µM forskolin on 1 µM MCh-induced contraction was gradually attenuated after repeated exposure to these agents. The values of percent contraction for MCh with forskolin were 43.6 ± 9.2%, and those values were increased to approximate 100% at the sixth application (n = 8, Figure 2B).




View larger version (31K):
[in this window]
[in a new window]
 
Figure 2. Subsequent relaxation by a direct activator of adenylyl cyclase after repeated exposure to an agent. (A) A typical example of the inhibitory effects of 1 µM (upper trace) and 10 µM (lower trace) forskolin against 1 µM MCh-induced contraction after repeated exposure to MCh with forskolin as in Figure 1. (B) Relationship between percent contraction for MCh with forskolin and the number of applications under these experimental conditions. Open circles, 1 µM forskolin; closed circles, 10 µM foskolin; open squares, 10 µM forskolin in the presence of 30 nM IbTX. The values of percent contraction for MCh with forskolin were expressed as in Figure 1.

 
Desensitization of KCa Channel Stimulatory Coupling
To examine the stimulatory coupling between ß-adrenergic receptors and KCa channels, we directly examined this relationship in on-cell patches. In separate experiments, KCa single channel currents were recorded in the cell-attached configuration during repeated exposure of ISO for 5 min every 15 min, and PKA was applied to inside-out patches in the same manner. Extracellular application of 1 µM ISO markedly augmented KCa channel activity and mean values of open probability (nPo) averaged over 5 min increased to 9.6 ± 3.1-fold (n = 6, Figure 3B). However, after repeated exposure to 1 µM ISO every 15 min, ISO channel stimulation was gradually attenuated with no change in unitary amplitude (Figure 3A). The values of fold stimulation of this channel by ISO at the third and sixth application were 5.3 ± 2.9- and 1.6 ± 1.1-fold (n = 6), respectively (P < 0.01, Figure 3B). This desensitization of stimulatory coupling was not due to channel rundown, as repeated application of 10 U/ml PKA to inside-out patches resulted in a sustained augmentation KCa channel activity (Figure 3C). Mean values of nPo increased 5.2 ± 1.8-fold (n = 12), and activation of channel open-state probability gradually increased with subsequent exposure to PKA. The values of fold stimulation of this channel by PKA at the third and sixth application were 6.9 ± 2.1- and 9.6 ± 2.0-fold (n = 12), respectively (P < 0.01, Figure 3D).






View larger version (103K):
[in this window]
[in a new window]
 
Figure 3. KCa channel activity induced by ß-agonists and protein kinase A (PKA) after repeated exposure to the agents. (A) A typical example of outward currents pass through a single KCa channel activated by 0.3 µM ISO after repeated application of this agent to a cell-attached patch. (B) Relationship between fold stimulation of KCa channel activation by ISO and the number of applications. (C) A typical continuous record of single KCa channels activated by the catalytic subunit of PKA (10 U/ml) after repeated exposure of this agent to an inside-out patch. (D) Relationship between fold stimulation of KCa channel activation by PKA and the number of applications. The values of fold stimulation of this channel by ISO and PKA at each application were expressed by taking open probability of this channel in the control as 1.0.

 
Desensitization of Inhibitory Effects on [Ca2+]i
To examine the desensitization effect at the level of [Ca2+]i, we made simultaneous measurements of tension and F340/F380 in intact muscle segments. The fura-2 loaded tissues were repeatedly exposed to 1 µM MCh for 7 min in the presence of 0.3 µM ISO (1 min before MCh) every 15 min. As shown in Figure 4A, ISO markedly reduced MCh-induced contractions (upper trace) and increases in [Ca2+]i (lower trace), but this effect was gradually attenuated after repeated exposure to ISO. The values of percent contraction and F340/F380 at the first and third application were 4.9 ± 1.9 and 17.9 ± 5.8% (n = 4), and 27.5 ± 8.9 and 60.6 ± 9.6% (n = 4), respectively (P < 0.01, Figure 4B). Consistent with experiments examining contraction alone, verapamil (3 µM) prevented the tachyphylaxis at the level of contraction and [Ca2+]i (Figure 4C). The values of percent contraction and F340/F380 for MCh with ISO at the first and third application were 3.2 ± 1.6 and 5.1 ± 2.9% (n = 4), and 26.0 ± 6.9 and 29.3 ± 7.4% (n = 4), respectively (not significant, Figure 4D).






View larger version (61K):
[in this window]
[in a new window]
 
Figure 4. Mobilization of intracellular Ca2+ after repeated exposure to ISO. (A) A typical example of simultaneous record of tension (upper trace) and F340/F380 (lower trace) after repeated exposure to 1 µM MCh with 0.3 µM ISO. (B) Relationship between percent contraction for MCh with ISO and the number of applications (open circles); relationship between percent F340/F380 and the number of applications (closed circles). (C) A typical example of simultaneous record of tension (upper trace) and F340/F380 (lower trace) after repeated exposure to 1 µM MCh with 0.3 µM ISO in the presence of 3 µM verapamil. (D) Relationship between percent contraction for MCh with ISO and the number of applications (open circles); relationship between percent F340/F380 and the number of applications (closed circles). Those values were expressed by taking tension and F340/F380 in response to 1 µM MCh in the control condition as 100%.

 
Similar to results at the level of contraction, the inhibitory effects of forskolin on [Ca2+]i did not display desensitization (Figure 5A). Application of 10 µM forskolin inhibited the MCh increase in force and [Ca2+]i without a loss of efficacy; the values of percent F340/F380 for MCh with forskolin were 54.2 ± 9.8 and 48.8 ± 8.6% (n = 4), respectively (not significant, Figure 5B). When the concentration of forskolin was lowered to 1 µM, the values of percent contraction and percent F340/F380 for MCh on forskolin were increased to 55.8 ± 10.8 and 60.9 ± 8.2% (n = 4), respectively (Figure 5C), and were not affected after repeated exposure to these agents. The values of percent contraction and percent F340/F380 at the third application of these agents were 70.1 ± 9.6 and 76.6 ± 6.9% (n = 4), respectively (not significant, Figure 5C).





View larger version (43K):
[in this window]
[in a new window]
 
Figure 5. Mobilization of intracellular Ca2+ after repeated exposure to foskolin. (A) A typical example of simultaneous record of tension (upper trace) and F340/F380 (lower trace) after repeated exposure to 1 µM MCh with 10 µM forskolin. (B) Relationship between percent contraction for MCh with 10 µM (B) and 1 µM (C) forskolin, and the number of applications (open circles); relationship between percent F340/F380 for these agents and the number of applications (closed circles). Those values were expressed as in Figure 4B.

 
Role of KCa Channel Suppression on Ca2+ Mobilization via VDCC Channels
To further explore the relationship between KCa stimulation and VDCC activity, we examined contractile and [Ca2+]i responses in the presence of inhibitors of both channel types. When IbTX (30 nM) was applied to tissues precontracted by 1 µM MCh, an increase in contraction and [Ca2+]i was observed (Figure 6A). The percent contraction and F340/F380 were increased to 128.6 ± 8.6 and 133.7 ± 9.6% (n = 4), respectively (Figure 6B). Verapamil (0.1-10 µM) prevented this increase, however, in a concentration-dependent manner, limiting the increases to 116.8 ± 6.8 and 120.4 ± 7.9% (n = 4) for contraction and [Ca2+]i, respectively, at 0.3 µM (P < 0.05, Figures 6B and 6C) and to 96.1 ± 6.2 and 97.6 ± 2.9% (n = 4), respectively, at 3 µM (P < 0.01, Figures 6B and 6C). Verapamil alone (3 µM) only modestly inhibited contraction and F340/F380 induced by MCh. The values of percent contraction and F340/F380 for MCh with 3 µM verapamil were 94.1 ± 6.2 and 95.6 ± 3.9% (n = 4), respectively.





View larger version (48K):
[in this window]
[in a new window]
 
Figure 6. Relationship between KCa channels and VDC channels. (A) A typical example of simultaneous record of tension (upper trace) and F340/F380 (lower trace) of the inhibitory effects of verapamil on iberiotoxin (IbTX)-induced contraction in the presence of MCh throughout the experiments. (B) Values of percent contraction for 30 nM IbTX with verapamil (0.03–3 µM) inhibition. (C) Values of percent F240/F380 for 30 nM IbTX with verapamil (0.03–3 µM) inhibition. Those values were expressed by taking tension and F340/F380 in response to 1 µM MCh in the control condition as 100%. *P < 0.05, **P < 0.01.

 
Concentration of Intracellular cAMP after Repeated Exposure to ISO and Forskolin
Finally, we examined desensitization at the level of generation of intracellular cAMP. Exposure of tissues to 0.3 µM ISO for 10 min increased intracellular cAMP from 4.6 ± 3.2 to 12.5 ± 3.5 pmol/mg (n = 6, P < 0.01; Figure 7A). However, after repeated exposure to ISO for 10 min every 30 min, concentration of intracellular cAMP was markedly decreased to 5.7 ± 2.4 pmol/mg at the ninth application (n = 6, P < 0.05). Conversely, when tissues were repeatedly exposed to 10 µM forskolin in the same way, no desensitization was observed. Forskolin stimulated cAMP concentration to 288.9 ± 162.9 pmol/mg initially and to 477.8 ± 107.4 pmol/mg at the ninth application (n = 6, P < 0.05; Figure 7B).




View larger version (19K):
[in this window]
[in a new window]
 
Figure 7. Intracellular cAMP accumulation after repeated exposure to ISO and forskolin. (A) Concentrations of intracellular cAMP induced by 0.3 µM ISO at the first (control, open column) and ninth (closed column) application of this agent. (B) Concentrations of intracellular cAMP induced by 10 µM forskolin at the first (control, open column) and ninth (closed column) application of this agent. *P < 0.05.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In the present study, we demonstrate for the first time the involvement of Ca2+ mobilization regulated by KCa channels as an important mechanism underlying tachyphylaxis to ß-agonists in airway smooth muscle. ß-Adrenergic stimulatory coupling to KCa channels and inhibition of cholinergic force production is progressively lost with repeated application of ß-agonist, whereas forskolin-stimulated coupling does not desensitize (Figures 1, 2, 4, and 5). Consistent with a causal relationship between loss of KCa channel stimulatory activity and tachyphylaxis, pharmacologic inhibition of KCa channels augments the loss of relaxant activity with repeated ß-agonist exposure. Moreover, in the presence of verapamil, little loss of ß-agonist potency was observed. Because ß-agonist stimulatory coupling to KCa channels is an important regulator of VDCC activity during muscarinic contractions (Figure 6), this finding suggests that augmented Ca2+ influx through VDCC leads to rapid desensitization of ß-adrenergic receptors and tachyphylaxis. The effect of verapamil could not be explained by a progressive decrease in sarcoplasmic reticulum Ca2+, as repeated contractions in the presence of verapamil alone did not decrease force production (not shown). Thus, our results suggest that ß-adrenergic desensitization is highly sensitive to VDCC activity. A recent study in hippocampal neurons indicates interactions between the ß2-adrenergic receptor and the {alpha}1.2 subunit of the L-type Ca2+ channel (25). Although no evidence of interaction between the ß2-adrenergic receptor and smooth muscle VDCC has been reported, our findings suggest a surprising dependence of desensitization on VDCC activity. Thus, Ca2+ influx through VDCC appears to promote tachyphylaxis to ß-agonists.

Muscarinic stimulation of airway smooth muscle produces a sustained, global rise in [Ca2+]i, which would be expected to markedly activate KCa channels and prevent tissue depolarization. However, muscarinic receptor stimulation also produces a potent and direct inhibition of KCa channel activity (21). ß-Adrenergic receptor stimulation opens KCa channels, resulting in competitive antagonism at the level of membrane potential (15, 26), likely explaining the marked dependence of relaxation on KCa activity (1113). This competitive action can be seen in Figure 6, in which muscarinic increases in [Ca2+]i and tension are augmented by inhibition of KCa channels, an effect that occurs through stimulation of VDCC. Thus, VDCC activity appears to play an important role in ß-adrenergic relaxation in spite of the relatively modest effect of VDCC inhibitors alone in antagonizing muscarinic contraction. Our results indicate that VDCC regulates tachyphylaxis, rather than the VDCC being the key downstream target controlling contraction. Measurements of [Ca2+]i during repeated exposure to ß-agonist indicated that the ability of the agonist to inhibit cholinergic increases in [Ca2+]i also desensitized (Figure 4), providing further evidence of the functional importance of ß-adrenergic receptor/KCa channel stimulatory coupling in relaxation responses.

Desensitization of stimulatory coupling was directly established in patch clamp experiments showing a progressive loss of stimulation of channel activity by ISO with repeated exposure (Figure 3), similar in magnitude and time-course to that observed at the levels of force and [Ca2+]i (Figure 4). Because the progressive reduction in KCa channel activity by ß-agonists was mimicked by outside-out patches (data not shown), membrane-delimited pathways may be involved in the phenomenon. Previous reports have demonstrated that an augmentation in KCa channel activity is a key component of the relaxant action and membrane hyperpolarization induced by ß-agonists (27). As shown in Figure 6, IbTX increased tension and [Ca2+]i induced by MCh, and verapamil suppressed the effects induced by IbTX, demonstrating that inhibition of KCa channel activity results in increased Ca2+ influx through VDCC, and augmented force production (28). We show that tachyphylaxis to ß-agonists also occurs at the level of [Ca2+]i as repeated exposure to ß-agonists resulted in gradual increase in [Ca2+]i (Figure 4), indicating a loss of efficacy in preventing Ca2+ mobilization. A substantial component of this increase in [Ca2+]i occurs through the activation of VDCC, as the overall increase in [Ca2+]i is partially inhibited by verapamil (Figure 4) and nifedipine (not shown). Strikingly, it is this component that appears to account for the ß-adrenergic desensitization, as inhibition of VDCC eliminates tachyphylaxis at the level of [Ca2+]i (Figure 4). Hence, Ca2+ mobilization through VDCC regulated by KCa channel activity leads to tachyphylaxis to ß-agonists.

Stimulatory coupling between ß-adrenergic receptors and KCa channels is involved in functional relaxation, and desensitization of this coupling correlates extremely well with loss of ß-adrenergic efficacy. As shown in Figure 1, the first application of ISO is markedly less effective at reducing tension in the presence of IbTX, and this effect was also observed at the level of [Ca2+]i (data not shown). However, our data also point to KCa channel–independent mechanisms underlying relaxation induced by ß-agonists in airway smooth muscle, as previous reported (14, 29). Thus, although reduced in efficacy, ß-agonists relax tracheal smooth muscle in the presence of 30 nM IbTX (Figure 1B).

Finally, we show that desensitization of ß-adrenergic stimulatory coupling is not associated with a loss of efficacy downstream of the receptor/G protein complex (Figures 25). The inhibitory effects of forskolin on contraction and [Ca2+]i were not attenuated with repeated exposure to this agent, suggesting that desensitization occurs at the level of ß-adrenergic receptor/adenylyl cyclase coupling. Moreover, cAMP generation was not attenuated following repeated exposure to forskolin (Figure 7), whereas adenylyl cyclase activity was significantly attenuated after repeated exposure to ISO. Thus, tachyphylaxis is considered to be associated with an uncoupling of the ß-adrenergic receptor from target molecules rather than a loss of efficacy of downstream signaling events, and is consistent with the well characterized phosphorylation and arrestin-mediated internalization of ß2-adrenergic receptors (30, 31). However, our data also demonstrate that forskolin relaxation is desensitized in the presence of IbTX (Figure 2B), revealing a postreceptor desensitization of adenylyl cyclase or downstream effectors that occurs with augmented Ca2+ influx.

In summary, we have shown that a progressive loss of ß-adrenergic stimulatory coupling to KCa channels plays a major role in the loss of ß-adrenergic relaxation efficacy that occurs with tachyphylaxis. Loss of this stimulatory coupling is reflected in a parallel failure to effectively decrease [Ca2+]i. The mechanism underlying loss of coupling efficiency is upstream of the KCa channel and appears to result from receptor uncoupling. These results may provide a rationale for other strategies aimed at activating this system through nondesensitizing pathways.

Received in original form September 30, 2002

Received in final form March 10, 2003


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kume, H., and K. Takagi. 1997. Inhibitory effects of GS on desensitization of ß-adrenergic receptors in tracheal smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 273:L556–L564.[Abstract/Free Full Text]
  2. Kume, H., and K. Takagi. 1999. Inhibition of ß-adrenergic desensitization by KCa channels in human trachealis. Am. J. Respir. Crit. Care Med. 159:452–460.[Abstract/Free Full Text]
  3. Stephen, W. C., T. W. Chick, B. P. Avner, and J. W. Jenne. 1980. Tachyphylaxis to inhaled isoproterenol and the effects of methylpredonisolone in dogs. J. Allergy Clin. Immunol. 65:105–109.[CrossRef][Medline]
  4. Sears, M. R., D. R. Taylar, C. G. Print, D. C. Lake, Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and G. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391–1396.[CrossRef][Medline]
  5. Van Schayck, C. P., S. J. Grasfura, M. B. Visil, E. Dompeling, C. van Weel, and L. C. A. van Herwaaden. 1990. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J. Allergy Clin. Immunol. 86:786–800.
  6. Tan, K. S., A. Grove, A. Mclean, Y. Gnosspelius, I. P. Hall, and B. J. Lipworth. 1997. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am. J. Respir. Crit. Care Med. 156:28–35.[Abstract/Free Full Text]
  7. Cheung, D., M. C. Timmers, A. H. Zwinderman, E. H. Bel, J. H. Dijkman, and P. J. Sterk. 1992. Long-term effects of a long-acting ß2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with asthma. N. Engl. J. Med. 327:1198–1203.[Abstract]
  8. Wills-Karp, M., Y. Uchida, J. Y. Lee, J. Jinot, A. Hirata, and F. Hirata. 1993. Organ culture with proinflammatory cytokines reproduces impairment of the ß-adrenoceptor–mediated relaxation in tracheas of a guinea pig antigen model. Am. J. Respir. Cell Mol. Biol. 8:153–159.
  9. Shore, S. A., J. Laporte, I. P. Hall, E. Hardy, and R. A. Panettieri, Jr. 1997. Effect of IL-1ß on responses of cultured human airway smooth muscle cells to bronchodilator agonists. Am. J. Respir. Cell Mol. Biol. 16:702–712.[Abstract]
  10. Kume, H., S. Ito, Y. Ito Y, and K. Yamaki. 2001. Role of lysophosphatidylcholine in the desensitization of ß-adrenergic receptors by Ca2+ sensitization in tracheal smooth muscle. Am. J. Respir. Cell Mol. Biol. 25:291–298.[Abstract/Free Full Text]
  11. Jones, T. R., L. Charette, M. L. Garcia, and G. J. Kaczorowski. 1990. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca2+- activated K+ channel inhibitor. J. Pharmacol. Exp. Ther. 255:607–706.
  12. Murray, M. A., L. Berrry, S. J. Cook, R. W. Foster, K. A. Green, and R. C. Small. 1991. Guinea-pig isolated trachealis: the effects of charybdotoxin on mechanical activity, membrane potential chages and the activity of plasmmalemmal K+-channels. Br. J. Pharmacol. 103:1814–1818.[Medline]
  13. Hiramatsu, T., H. Kume, M. I. Kotlikoff, and K. Takagi. 1994. Role of calcium-activated potassium channels in the relaxation of tracheal smooth muscles by forskolin. Clin. Exp. Pharmacol. Physiol. 21:367–375.[Medline]
  14. Barnes, P. J. 1995. ß-Adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152:838–860.[Medline]
  15. Kume, H., A. Takai, H. Tokuno, and T. Tomita. 1989. Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation. Nature 341:152–154.[CrossRef][Medline]
  16. Nara, M., P. D. K. Dhulipala, Y-X. Wang, and M. I. Kotlikoff. 1998. Reconstruction of ß-adrenergic modulation of large conductance, calcium-activated potassium (Maxi-K) channels in Xenopus Oocytes. J. Biol. Chem. 273:14920–14924.[Abstract/Free Full Text]
  17. Kume, H., M. P. Graziano, and M. I. Kotlikoff. 1992. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding protein. Proc. Natl. Acad. Sci. USA 89:11051–11055.[Abstract/Free Full Text]
  18. Spicuzza, L., M. G. Belvisi, M. A. Birrell, P. J. Barnes, D. J. Hele, and M. A. Giembycz. 2001. Evidence that the anti-spasmogenic effect of the ß-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase. Br. J. Pharmacol. 133:1201–1212.[CrossRef][Medline]
  19. Kume, H., K. Mikawa, K. Takagi, and M. I. Kotlikoff. 1995. Role of G proteins and KCa channels in the muscarinic and ß-adrenergic regulation of airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 268:L221–L229.[Abstract/Free Full Text]
  20. Ito, S., H. Kume, H. Honjo, H. Katoh, I. Kodama, K. Yamaki, and H. Hayashi. 2001. Possible involvement of Rho kinase in Ca2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L1218–L1224.[Abstract/Free Full Text]
  21. Kume, H., and M. I. Kotlikoff. 1991. Muscarinic inhibition of single KCa channels in smooth muscle by a pertussis-sensitive G protein. Am. J. Physiol. Cell Physiol. 261:C1204–C1209.[Abstract/Free Full Text]
  22. Kume, H., I. P. Hall, R. J. Washabau, K. Takagi, and M. I. Kotlikoff. 1994. ß-Adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J. Clin. Invest. 93:371–379.
  23. Cortijo, J., V. Villagrasa, R. Pons, L. Berto, M. Marti-Cabrera, M. Martinez-Losa, T. Domenech, J. Beleta, and E. J. Morcillo. 1999. Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. Br. J. Pharmacol. 127:1641–1651.[CrossRef][Medline]
  24. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–273.[Free Full Text]
  25. Davare, M. A., V. Avdonin, D. D. Hall, E. M. Penden, A. Burette, R. J. Weinberg, M. C. Horne, T. Hoshi, and J. W. Hell. 2001. A b2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav 1.2. Science 193:98–101.
  26. Oshiro, T., T. Sasaki, M. Nara, T. Tamada, S. Shimura, Y. Maruyama, and K. Shirato. 2000. Suppression of Maxi-K channel and membrane depolarization by synthetic polycations in singl myocytes. Am. J. Respir. Cell Mol. Biol. 22:528–534.[Abstract/Free Full Text]
  27. Small, R. C., P. Chiu, S. J. Cook, R. W. Foster, and L. Isaac. 1993. ß-Adrenoceptor agonists in bronchial asthma: role of K+-channel opening in mediating their brochdiltor effects. Clin. Exp. Allergy 23:802–811.[CrossRef][Medline]
  28. Brayden, J. E., and M. T. Nelson. 1992. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256:532–535.[Abstract/Free Full Text]
  29. Khac, L. D., A. Mokhtari, M. Renner, and S. Harbon. 1991. Activation of ß-adrenergic receptors inhibits Ca2+ entry-mediated generation of inositol phosphates in the guinea pig myometrium, a cyclic AMP-independent event. Mol. Pharmacol. 41:509–519.
  30. Benovic, J. L., R. H. Strasser, M. G. Caron, and R. J. Lefkowitz. 1986. ß-Adrenergic receptor kinase: Identification of a novel protein kinase that phosphorylates the agonists-occupied form of the receptor. Proc. Natl. Acad. Sci. USA 83:2797–2801.[Abstract/Free Full Text]
  31. Lhose, M. J., J. L. Bonovic, J. Codina, M. G. Caron, and R. J. Lefkowitz. 1990. ß-Arrestin: a protein that regulates ß-adrenergic receptor function. Science 248:1547–1550.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0197OCv1
29/3/359    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kume, H.
Right arrow Articles by Kotlikoff, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kume, H.
Right arrow Articles by Kotlikoff, M. I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society.